LANSOPRAZOLE | A203083 | HETERO LABS LTD UNIT III
Highest NADAC/Unit
$0.1470
per ea
Lowest NADAC/Unit
$0.1071
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722057030LANSOPRAZOLE DR 15 MG CAPSULE | $0.1470 | EA | Generic | — | 2026-08-19 |
| 31722057090LANSOPRAZOLE DR 15 MG CAPSULE | $0.1470 | EA | Generic | — | 2026-08-19 |
| 82009003905LANSOPRAZOLE DR 30 MG CAPSULE | $0.1071 | EA | Generic | — | 2026-08-19 |
| 31722057105LANSOPRAZOLE DR 30 MG CAPSULE | $0.1071 | EA | Generic | — | 2026-08-19 |
| 31722057130LANSOPRAZOLE DR 30 MG CAPSULE | $0.1071 | EA | Generic | — | 2026-08-19 |
| 31722057190LANSOPRAZOLE DR 30 MG CAPSULE | $0.1071 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.